Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 1639  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (1,514 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References
 ::  Article Figures

 Article Access Statistics
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal


  Table of Contents     
Year : 2019  |  Volume : 65  |  Issue : 4  |  Page : 251-252

Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels

1 Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
2 Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Date of Web Publication14-Oct-2019

Correspondence Address:
Y Y Lin
Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpgm.JPGM_145_19

Rights and Permissions

How to cite this article:
Lin Y Y, Cho S F. Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels. J Postgrad Med 2019;65:251-2

How to cite this URL:
Lin Y Y, Cho S F. Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels. J Postgrad Med [serial online] 2019 [cited 2023 Jun 1];65:251-2. Available from:

Lung cancer is well known as one of the most lethal malignancies due to difficulty in early diagnosis and high potential of distal metastases. We report a 73-year-old male with medical history of pulmonary tuberculosis and chronic cough who presented for evaluation of weight loss of 6 kg (from 61 kg to 55 kg) over the past 6 weeks. On physical examination, no obvious abnormality was observed. Chest X-ray showed post-tuberculosis fibrotic lesion in the left lung field [Figure 1]a. However, laboratory investigations revealed significantly elevated serum levels of carbohydrate antigen 19-9 (Ca 19-9)(38,070.19 U/mL) and carcinoembryonic antigen (CEA) (4,398 ng/ml). Colonoscopy and esophagogastroduodenoscopy showed no obvious tumor lesion. Abdominal ultrasonography revealed multiple hypoechoic lesions in the liver suggestive of metastases. Contrast enhanced computed tomography (CT) of chest and abdomen revealed postinflammatory fibrosis and pleural nodular thickening at upper and lingual lobes of left lung [Figure 1]b, as well as metastatic liver tumors. To further investigate the origin of the malignancy, whole body positron emission tomography/computed tomography (PET/CT) was performed, which revealed heterogeneously high grade of fluorodeoxyglucose (FDG) avidity exactly in the site of suspected postinflammatory fibrosis with maximal standardized uptake value (SUVmax) of 6.5 [Figure 1]c as well as the thickening of left pleura found on the previous CT scan, with SUVmax value of 9.1 [Figure 1]C1. Moreover, multiple lymph nodes with reactive FDG avid in periaortal or subaortal area were also observed [Figure 1]d. The patient underwent video-assisted thoracoscopic surgery, and wedge resection and a pleural biopsy were performed. Histopathological examination revealed poorly differentiated adenocarcinoma [Figure 2]a. Immunohistochemical study of the tumor cells showed positive for CK7 [Figure 2]b, TTF-1 [Figure 2]c and CA19-9 [Figure 2]d. A liver specimen was analyzed retrospectively, and an immunohistochemical study was positive for CK7 [Figure 2]B1 and TTF-1 [Figure 2]C1. In addition, a strong expression of CA19-9 [Figure 2]D1 was found. Genetic examination was negative for mutation of epidermal growth factor receptor. The patient was started on recommended systemic chemotherapy and followed up regularly.
Figure 1: (a) Chest X-ray showed infiltration over the left lung field; (b) high resolution computed tomography scan revealed fibrosis and pleural nodular thickening in upper and lingual lobes of left lung; (c)FDG positron emission tomography/computed tomography fused imaging revealed a hypermetabolic lesion (measuring 2.0 cm) in the upper lobe of the left lung attached to the pleura. There was left pleural thickening with high grade FDG uptake, compatible with multifocal pleural metastasis (C1); (d) multiple FDG-avid metastatic lymphadenopathies in the mediastinal and left pulmonary hilar regions, as well as FDG-avid metastatic tumors in bilateral hepatic lobes were also seen on whole-body imaging

Click here to view
Figure 2: H and E-stained specimen of the lung revealed poorly differentiated adenocarcinoma composed of pleomorphic neoplastic cells arranged in a micropapillary pattern within desmoplastic or fibrous stroma (a, 200×). The tumor cells of the lung were immunoreactive for CK7 (b), TTF-1 (c), and CA19-9 (d). The liver specimen also showed the same immunoprofiles (B1, C1, and D1)

Click here to view

The initial suspected diagnosis of this patient tended towards a primary malignancy of the gastrointestinal tract because of metastases in the liver; which was supported by extremely high levels of CEA and CA19-9. However PET/CT study indicated possibility of primary lung cancer after it revealed high FDG avidity in areas where the initial CT findings were suggestive of fibrocavitary opacity with fibrosis and thickened pleura. Our experience in investigating this patient reiterates the superiority of PET/CT over conventional CT scan in detecting the origin of malignancy because the former incorporates both anatomic and functional evaluations. For a suspicious lesion with normal or near normal anatomic structure on CT scan, PET/CT can further distinguish cancer cells from normal cells based on higher metabolic activity in cancer cells. Due to its higher sensitivity, previous studies have also stated that PET/CT scan is a better tool to investigate the origin of a malignancy than conventional CT scan.[1],[2]

Although PET/CT provided important information in this case, there were still some other clues implicating the lung as the primary malignancy. The patient had other known risk factors for developing lung cancer such as being a long-term smoker; and past history of receiving drug therapy for his rheumatoid arthritis [3] and having pulmonary tuberculosis.[4] Moreover, immunohistochemical study to evaluate expression of cytokines, such as cytokerotin-7 and cytokerotin-20 provided additional information.

Our patient had very high CA 19-9 level at diagnosis. CA 19-9 is also called sialylated Lewis(a) antigen which is a mucus glycoprotein commonly present in high amounts in adenocarcinomas of the colon, pancreas, and stomach. With respect to its association with cancer, a growing amount of data suggested that its carbohydrate structure is the ligand for E-selectin. In addition, sialylated Lewis(a) and sialylated Lewis(x) are believed to have important roles in selectin-mediated adhesion of cancer cells to vascular endothelium. This process is believed to be closely associated with hematogenous spread of cancers.[5] CA 19-9 is also found in the glands of bronchi and bronchioles. It is our postulation that in the present case the primary lung malignant lesion had a high predilection for metastasizing which explains the high serum CA 19-9 levels.

In conclusion, this case reiterates the importance of doing a whole body PET/CT scan study to identify an occult primary malignant lesion.

Declaration of patient consent

The authors certify that appropriate patient consent was obtained.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

 :: References Top

Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007;109:292-9.  Back to cited text no. 1
Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: Systematic review and meta-analysis. Eur Radiol 2009;19:731-44.  Back to cited text no. 2
Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, et al. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 2013;52:91-8.  Back to cited text no. 3
Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: A population cohort study. J Thorac Oncol 2011;6:32-7.  Back to cited text no. 4
Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004;95:377-84.  Back to cited text no. 5


  [Figure 1], [Figure 2]


Print this article  Email this article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow